QuickView for PRKCB;jsessionid=FB2DAD4E23703243139B57364653F434;jsessionid=D9761C9DE8AED3438DC8431008D82EA9;jsessionid=2BC8547722C00C5C3F7352AD7F662726;jsessionid=355E94BBB4AECCB3AB8D70AD8399EE32;jsessionid=87897174060DA9B2CB3F5CC0B98C7108 (gene)

1. Validation of PRKCB Immunohistochemistry as a Biomarker for the Diagnosis of Ewing Sarcoma.
2. PRKCB is relevant to prognosis of lung adenocarcinoma through methylation and immune infiltration.
3. Novel CD63-PRKCB fusion in a case of pigmented epithelioid melanocytoma.
4. Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Bio…
5. Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary b…

There were no clinical trials for PRKCB;jsessionid=FB2DAD4E23703243139B57364653F434;jsessionid=D9761C9DE8AED3438DC8431008D82EA9;jsessionid=2BC8547722C00C5C3F7352AD7F662726;jsessionid=355E94BBB4AECCB3AB8D70AD8399EE32;jsessionid=87897174060DA9B2CB3F5CC0B98C7108